ACTEMRA sol inj 162 mg/0.9 ml stylo préremp 4 pce

7680669310011 CH-66931 L04AC07 07.15.0.

Active substances:

ACTEMRA sol inj 162 mg/0.9 ml stylo préremp 4 pce
ACTEMRA sol inj 162 mg/0.9 ml stylo préremp 4 pce
1 / 2
Fiches Amavita / Sun Store / Coop Vitality

Details

Product number
6693101
CPT
-
Packaging group
4
Unit
Injektor(en), vorgefüllt/Pen
Composition
tocilizumabum 162 mg, polysorbatum 80, arginini hydrochloridum, methioninum, histidinum, histidini hydrochloridum monohydricum, aqua ad iniectabile q.s. ad solutionem pro 0.9 ml.

Articles (1)

Actemra 162 mg/0.9 ml, Injektionslösung in einem Fertigpen zur subkutanen Anwendung
Injektionslösung
4
View

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
tocilizumabum
162.0 MG Substance Wirkstoff (Principe actif)
polysorbatum 80
- Substance HNIDK
arginini hydrochloridum
- Substance HNIDK
methioninum
- Substance HNIDK
histidinum
- Substance HNIDK
histidini hydrochloridum monohydricum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK

Reimbursement information

Public price
CHF 1042.95
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/03/2019

Authorization holder

Roche Pharma (Schweiz) AG

4058 Basel

Authorization information

Swissmedic authorization number
66931
Drug name
Actemra, Injektionslösung in einem Fertigpen zur subkutanen Anwendung
Galenic form
LSPA
ATC Code
L04AC07
Authorization status
Z
Dispensation category
A
First authorization
10/12/2018
Authorization expiration date
31/12/9999
IT number
07.15.0.
Domain
Human medicine
Field of application
Rheumatoide Arthritis, Riesenzellarteriitis, polyartikuläre juvenile idiopathische Arthritis, systemische juvenile idiopathische Arthritis

Packaging details

Description (FR)
ACTEMRA sol inj 162 mg/0.9 ml stylo préremp 4 pce
Description (DE)
ACTEMRA Inj Lös 162 mg/0.9 ml Fertigpen 4 Stk
Market launch
10/12/2018
Narcotic (BTM)
No
Buy us a coffee Explore the data